UnitedHealth Group Incorporated $UNH Stock: Voya Investment Management LLC Reduces Stake

UnitedHealth Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Voya Investment Management cut its UnitedHealth stake by 19.2% in the third quarter, selling 463,430 shares; it still held about 1.96 million shares worth $717.9 million.
  • UnitedHealth reported quarterly EPS of $4.69, beating the $4.14 consensus, and revenue of $112.72 billion, above expectations. Revenue was down 0.4% year over year.
  • Analysts’ consensus rating was “Moderate Buy,” with an average price target of $463.93. The company also declared a quarterly dividend of $2.32 per share, equivalent to a 2.4% yield.
  • Interested in UnitedHealth Group? Here are five stocks we like better.

Voya Investment Management LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 19.2% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,956,183 shares of the healthcare conglomerate's stock after selling 463,430 shares during the period. Voya Investment Management LLC owned 0.22% of UnitedHealth Group worth $717,879,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Corient Private Wealth LP acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth about $245,516,000. Legal & General Group Plc bought a new stake in UnitedHealth Group during the 2nd quarter valued at approximately $2,444,928,000. Jupiter Topco LLC acquired a new stake in UnitedHealth Group in the 2nd quarter valued at approximately $2,019,844,000. BlackRock Inc. increased its position in UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock worth $31,946,594,000 after buying an additional 3,395,530 shares during the period. Finally, Canada Pension Plan Investment Board acquired a new position in shares of UnitedHealth Group during the second quarter worth approximately $971,757,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction on Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Corporate insiders own 0.19% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH stock opened at $389.45 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $255.96 and a 12 month high of $461.62. The company has a market capitalization of $348.96 billion, a P/E ratio of 22.24, a P/E/G ratio of 1.49 and a beta of 0.51. The stock has a 50 day moving average of $391.42 and a two-hundred day moving average of $366.73. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.14 by $0.55. The business had revenue of $112.72 billion for the quarter, compared to analysts' expectations of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. UnitedHealth Group's quarterly revenue was down .4% on a year-over-year basis. During the same period in the previous year, the business posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be issued a $2.32 dividend. This represents a $9.28 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Monday, December 7th. UnitedHealth Group's payout ratio is 53.00%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on UNH shares. Wells Fargo & Company reduced their price objective on UnitedHealth Group from $526.00 to $487.00 and set an "overweight" rating for the company in a research report on Tuesday, October 27th. KeyCorp reaffirmed an "overweight" rating on shares of UnitedHealth Group in a research report on Wednesday, October 14th. Stephens set a $500.00 target price on shares of UnitedHealth Group in a research note on Friday, October 16th. Erste Group Bank downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Thursday, August 27th. Finally, HC Wainwright set a $500.00 price objective on shares of UnitedHealth Group in a report on Friday, October 16th. Twenty research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company's stock. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and a consensus target price of $463.93.

Read Our Latest Stock Analysis on UNH

Top UnitedHealth Group Stories

Here are a few of the latest stories about UNH:

  • Neutral Sentiment: A report says Meridiem Capital Partners sold its UnitedHealth shares in the third quarter. This is a limited, backward-looking signal from one fund, rather than evidence of a broad investor retreat. Read article
  • Negative Sentiment: Sen. Elizabeth Warren called for breaking up major healthcare conglomerates, while coverage also cited a Senate breakup bill. The prospect of structural changes adds policy uncertainty for UnitedHealth and contributed to selling pressure. Read article
  • Negative Sentiment: UnitedHealth’s weakness also weighed on healthcare funds with significant exposure to the company, potentially amplifying the impact of the stock’s decline. Read article

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines